Clinical Trials on Prostatic Neoplasms in New Zealand

Total 16879 results

NYU Langone Health

Terminated

Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer

Prostate Cancer

United States
NYU Langone Health

Completed

PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

PSMA Imaging of Localized Prostate Cancer

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

Neoadjuvant J591 Treatment for Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Modifications to Radical Prostatectomy: Feasibility Study

Prostate Cancer

United States
Beth Israel Medical Center
Bayer

Terminated

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Prostate Cancer

United States
Columbia University
Celgene Corporation

Completed

Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Rockefeller University

Completed

Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
PSMA Development Corp, LLC

Completed

Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel

Prostate Cancer

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer

Prostate Cancer | Hormone Refractory Prostate Cancer

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Bayer

Completed

Multi-academic Center Study of Xofigo Patients

Prostate Cancer, Castration Resistant

United States
KangLaiTe USA

Terminated

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

Prostate Cancer

United States
Novartis Pharmaceuticals

Completed

Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer

Prostate Cancer

Saudi Arabia, Taiwan, Korea, Republic of, Lebanon, Brazil, China, New Zealand, Australia, Thailand, Kuwait
Johnson & Johnson Private Limited

Withdrawn

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostate Cancer

India
Roswell Park Cancer Institute

Terminated

Guided Biopsy for Mapping Prostate Cancer (HIT)

Prostate Cancer

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer (ASPIRE-PCa)

Prostate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate Cancer

Spain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
University of Alabama at Birmingham
Amgen

Completed

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Metastatic Castration-resistant Prostate Cancer

United States
Novartis Pharmaceuticals

Terminated

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Hormone Refractory Prostate Cancer Disease

United States
Memorial Sloan Kettering Cancer Center
Celgene Corporation

Completed

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Prostate Cancer | Castration Resistant Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Capcure

Completed

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

Cancer | Prostate

United States
Maimonides Medical Center

Completed

Reduction of Prostate Biopsy Morbidity

Prostate Cancer

United States
NYU Langone Health

Completed

Investigating and Characterizing the Immune Response to Prostate Cancer

Prostate Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Prostate Cancer

United States
New Mexico Cancer Care Alliance

Terminated

Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer

Prostate Cancer

United States
Progenics Pharmaceuticals, Inc.

Completed

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Prostate Cancer

United States
Accuray Incorporated

Completed

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Prostatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic Cancer

United States
DisperSol Technologies, LLC
Translational Drug Development

Active, not recruiting

PK and Dose Escalation and Expansion Study of DST-2970

Prostate Cancer

United States
Sanofi

Completed

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (TAXYNERGY)

Prostate Cancer Metastatic

United States, Canada
Dizal Pharmaceuticals

Terminated

Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC

Metastatic Castration Resistant Prostate Cancer

United States, Korea, Republic of
Memorial Sloan Kettering Cancer Center

No longer available

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Recurrent Prostate Cancer | Prostate Cancer

United States
Weill Medical College of Cornell University

Terminated

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Prostate Cancer

United States
NYU Langone Health

Completed

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (SIBRT)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Study of Focal Cryoablation in Low-Risk Prostate Cancer

Prostate Cancer

United States
Weill Medical College of Cornell University

Terminated

Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer

Prostate Cancer

United States
Columbia University
Genentech, Inc.

Terminated

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Columbia University

Completed

Optical Tomography in Prostate Cancer

Prostate Cancer

United States
Matthew Galsky

Completed

Metformin for Rising PSA Remote Trial (M-RePoRT)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Internal Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States
NYU Langone Health
Trod Medical N.V.

Completed

MRI-Targeted Focal Ablation of the Prostate in Men With Prostate Cancer (FUSAblate)

Prostate Cancer

United States
Weill Medical College of Cornell University

Completed

Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
NYU Langone Health

Terminated

Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer

Prostate Cancer

United States
NYU Langone Health
Dendreon

Terminated

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
Weill Medical College of Cornell University

Terminated

Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

Prostate Cancer

United States

Clinical Trials on Prostatic Neoplasms in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations